PC Jeweller Reports No Fund Utilization Deviation

Total amount raised during Q4 FY26: ₹556.43 crore through six tranches of warrant conversions:
January 22, 2026: ₹28.89 crore
January 31, 2026: ₹216.01 crore
February 24, 2026: ₹45.20 crore
March 23, 2026: ₹148.30 crore
March 28, 2026: ₹84.71 crore
March 31, 2026: ₹33.32 crore
Total utilization during quarter: ₹481.24 crore
Unutilized amount in monitoring account at quarter end: ₹75.33 crore

First Preferential Issue (Approved August 8, 2024):

Originally allotted 48,08,02,500 Fully Convertible Warrants in two tranches (September 30, 2024: 11,50,00,000 warrants; October 11, 2024: 36,58,02,500 warrants)
During Q4 FY26, allotted 132,01,08,320 equity shares (face value ₹1) upon warrant conversions
Original objects: Repayment of outstanding debts (₹2,025.00 crore), working capital requirement (₹529.69 crore), general corporate purposes (₹150.00 crore), issue expenses (₹0.45 crore)
Modified allocation due to undersubscription: Repayment of debts (₹2,022.73 crore), working capital (₹529.10 crore), corporate purposes (₹149.83 crore), issue expenses (₹0.45 crore)
Total utilized till March 31, 2026: Repayment of debts (₹1,310.47 crore), working capital (₹529.10 crore), corporate purposes (₹149.83 crore), issue expenses (₹0.45 crore)

Second Preferential Issue (Approved August 10, 2025):

Allotted 9,72,22,222 Fully Convertible Warrants to Promoter and 18,05,55,555 equity shares to Non-Promoter, Public Category on September 18, 2025
No funds raised during Q4 FY26 under this issue
Original objects: Repayment of outstanding debts including interest (₹434.27 crore), working capital requirement (₹65.33 crore), issue expenses (₹0.40 crore)
Total utilized till March 31, 2026: Repayment of debts (₹303.52 crore), working capital (₹65.22 crore), issue expenses (₹0.00 crore)
Unutilized amount in monitoring account: ₹0.01 crore

Shareholder approval dates: August 8, 2024 and August 10, 2025
Stock exchange in-principle approvals: BSE and NSE on September 27, 2024 and September 9, 2025 respectively
Audit committee reviewed the statement
Monitoring agency: CARE Ratings Limited

First issue: Tentative utilization timeline until April 2026 for debt repayment
Second issue: Tentative utilization timeline until September 30, 2026 for debt repayment and March 31, 2027 for working capital